A detailed history of Allworth Financial LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Allworth Financial LP holds 164 shares of QURE stock, worth $934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
164
Previous 164 -0.0%
Holding current value
$934
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$4.39 - $5.43 $118 - $146
-27 Reduced 14.14%
164 $0
Q1 2024

Apr 25, 2024

SELL
$4.82 - $6.93 $3,856 - $5,544
-800 Reduced 80.73%
191 $0
Q4 2023

Jan 24, 2024

SELL
$5.63 - $8.27 $821 - $1,207
-146 Reduced 12.84%
991 $6,000
Q3 2023

Oct 31, 2023

BUY
$6.71 - $11.83 $6,528 - $11,510
973 Added 593.29%
1,137 $7,000
Q4 2022

Jan 13, 2023

SELL
$18.12 - $27.32 $1,087 - $1,639
-60 Reduced 26.79%
164 $0
Q3 2022

Oct 18, 2022

BUY
$16.98 - $25.54 $1,018 - $1,532
60 Added 36.59%
224 $4,000
Q1 2021

Apr 29, 2021

SELL
$29.24 - $42.03 $87 - $126
-3 Reduced 1.8%
164 $6,000
Q4 2020

Jan 26, 2021

BUY
$35.35 - $50.67 $106 - $152
3 Added 1.83%
167 $6,000
Q4 2019

Jan 16, 2020

BUY
$37.13 - $74.62 $6,089 - $12,237
164 New
164 $12,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $266M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.